StructoKabiven - Hong Kong[香港药品]

TOP

StructoKabiven

2015-05-10 15:29:54 来源: 作者: 【大中小】浏览:893次评论:0条

See related StructoKabiven information

Manufacturer	Fresenius Kabi
Distributor	Hong Kong: Zuellig/Macau: The Glory Medicina
Contents	Per 1206 mL Purified structured triglyceride 34 g, glucose (as monohydrate) 85 g, alanine 5.3 g, arginine 4.6 g, glycine 4.2 g, histidine 1.1 g, isoleucine 1.9 g, leucine 2.8 g, lysine (as acetate) 2.5 g, methionine 1.6 g, phenylalanine 1.9 g, proline 4.2 g, serine 2.5 g, taurine 0.38 g, threonine 1.7 g, tryptophan 0.76 g, tyrosine 0.15 g, valine 2.4 g, CaCl₂ (as dihydrate) 0.21 g, Na glycerophosphate (as hydrate) 1.6 g, Mg sulphate (as heptahydrate) 0.46 g, KCl 1.7 g, Na acetate (as trihydrate) 1.3 g, Zn sulphate (as heptahydrate) 0.005 g. Per 1904 mL Purified structured triglyceride 54 g, glucose (as monohydrate) 135 g, alanine 8.4 g, arginine 7.2 g, glycine 6.6 g, histidine 1.8 g, isoleucine 3 g, leucine 4.4 g, lysine (as acetate) 4 g, methionine 2.6 g, phenylalanine 3.1 g, proline 6.7 g, serine 3.9 g, taurine 0.6 g, threonine 2.6 g, tryptophan 1.2 g, tyrosine 0.24 g, valine 3.7 g, CaCl₂ (as dihydrate) 0.34 g, Na glycerophosphate (as hydrate) 2.5 g, Mg sulphate (as heptahydrate) 0.72 g, KCl 2.7 g, Na acetate (as trihydrate) 2 g, Zn sulphate (as heptahydrate) 0.008 g
Indications	Parenteral nutrition for adult patients when oral or enteral nutrition is impossible, insufficient or contraindicated.
Dosage	IV infusion in to a central vein. Individualised dosage. Nitrogen requirements in the normal nutritional state or in mild metabolic stress 0.1-0.15 g nitrogen/kg/day. Nitrogen requirements in moderate to high metabolic stress w/ or w/o malnutrition 0.15-0.25 g nitrogen/kg/day.
Contraindications	Hypersensitivity to egg- or soya protein. Severe hyperlipaemia, liver insufficiency & blood coagulation disorders; congenital errors of amino acid metabolism, severe renal insufficiency w/o access to hemofiltration or dialysis, acute shock, hyperglycemia, pathologically elevated serum electrolyte levels, acute pulmonary oedema, hyperhydration, decompensated cardiac insufficiency, hypotonic dehydration, hemophagocytotic syndrome, unstable conditions eg severe posttraumatic conditions, uncompensated DM, acute MI, metabolic acidosis, severe sepsis & hyperosmolar coma. Newborn or infant <2 yr.
Special Precautions	Monitor ability to eliminate fat. Correct electrolyte & fluid balance disturbances prior to infusion. Predisposition to electrolyte retention. Impaired lipid metabolism, renal & hepatic impairment, pancreatitis, hypothyroidism, sepsis. Monitor serum triglycerides, glucose, electrolytes, osmolarity, fluid balance, acid-base status, liver enzyme tests, blood cell count & coagulation. Phosphate & K intake should be controlled in patients w/ renal insufficiency. Lactic acidosis, insufficient cellular O₂ supply, increased serum osmolarity, malnourished patients. Hyperglycemia. Do not give w/ blood in the same infusion set. Childn. Pregnancy & lactation.
Adverse Drug Reactions	Nausea, headache, rise in body temp, elevated plasma levels of liver enzymes, ketone bodies & triglycerides. Rarely, tachycardia & HTN. View ADR Monitoring Form
Drug Interactions	Heparin. View more drug interactions with StructoKabiven
ATC Classification	A16AA - Amino acids and derivatives ; Used in treatment of alimentary tract and metabolism problems.